Navigation Links
Radiation Oncology Experts from 16 Countries Attend Technical University of Munich's International Conference on TomoTherapy

TomoTherapy Incorporated (NASDAQ: TOMO) announced today that Technical University of Munich, Germany, recently welcomed 175 radiation oncology experts from 16 countries to the ‘International Conference on the Clinical Use of TomoTherapy’. The two-day event featured 35 technical talks from doctors and physicists. Presentations covered the multiple cancer types clinicians are treating with CT-guided, helical TomoTherapySM and treatment protocols that show promise in gaining improved outcomes for patients.

MADISON, Wis. (Business Wire EON) October 29, 2008 -- "We were extremely pleased to host this exciting scientific meeting to explore the clinical use of TomoTherapy," said Prof. Michael Molls, M.D., chairman of Radiation Oncology, Klinikum Rechts der Isar, Technical University of Munich. "Our clinic has used TomoTherapy for the last 2 years in a project funded by the German Oncology research foundation. This new technology, which combines CT imaging with a linear accelerator in one device, allows us to treat patients with a higher accuracy and to better shape dose distributions to target tumour volumes."

Notable conference presentations included:

  • Patrick Kupelian, director of Clinical Research for Radiation Oncology at MD Anderson Cancer Center Orlando, Florida on TomoTherapy for prostate cancer; and Prof. Guy Storme, M.D., Ph.D., director of the Oncologic Center at UZ Brussel, Brussels, Belgium on the use of TomoTherapy for the treatment of head and neck tumours; "The gathered international clinicians enjoyed presentations covering many of the clinical possibilities for TomoTherapy," said Dr. Kupelian. "Evidenced in many presentations is the need for volumetric daily image guidance such as that provided on the TomoTherapy HiArt treatment system. It is important to continue such meetings to allow sharing of experience with the goal to deliver improved outcomes for our patients."

Prof. Storme added, "Meetings like this help us understand the range of possibilities with a platform like TomoTherapy and highlight the need for clinical Phase 3 studies to make most use of this technology which seems to have a beneficial effect for patients in reducing side effects."

Thomas 'Rock' Mackie, Ph.D., TomoTherapy co-founder and chairman of the board, discussed the experience of taking TomoTherapy from concept to clinical routine and thanked Technical University of Munich for organizing a successful conference.

"I am excited to see so many respected members of the international radiation oncology community gather to present the wonderful work they are doing with TomoTherapy," said Mackie. "It is a great opportunity for us to see the way the potential of this platform is being explored and how future developments will extend the possibilities."

About TomoTherapy Incorporated

TomoTherapy Incorporated has developed, markets and sells the TomoTherapy HiArt treatment system, an advanced radiation therapy system for the treatment of a wide variety of cancers. The HiArt treatment system combines integrated CT imaging with conformal radiation therapy to deliver sophisticated radiation treatments with speed and precision while reducing radiation exposure to surrounding healthy tissue. The company's stock is traded on the NASDAQ Global Select Market under the symbol TOMO. To learn more about TomoTherapy, please visit

2008 TomoTherapy Incorporated. All rights reserved. TomoTherapy, the TomoTherapy logo and HiArt are among trademarks, service marks or registered trademarks of TomoTherapy Incorporated.

Read the full story at

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Grupo IMO Hosts Symposium on Use of TomoTherapy for Stereotactic Radiosurgery and Stereotactic Body Radiation Procedures : Experts Detail HiArt Platform Advantages for Treatment of Brain, Lung, Pancreatic and Metastatic Cancers
2. OHSU Cancer Institute researcher: radiation, immunotherapy gives greater effectiveness
3. Cancer patients who receive neoadjuvant therapy followed by mastectomy may not need radiation
4. OHSU Cancer Institute researchers study breathing during radiation
5. Digirad Corporation Receives FDA 510(k) Clearance for nSPEED(R) Reconstruction Software for Improved Image Quality in Less Time With Less Radiation
6. Whole brain radiation increases risk of learning and memory problems in cancer patients
7. Radiation Oncology Services of America, Inc. Announces Formation of Scientific Advisory Board
8. Radiation Oncology Institute Campaign Raises $3 Million
9. Dr. Chad Levitt Joins North Georgia Radiation Oncology Center
10. Drug/radiation combo may help shrink established tumors
11. Grocery Manufacturers Association Strongly Supports U.S. Food & Drug Administration Decision on the Irradiation of Fresh Produce for Foodborne Pathogen Control
Post Your Comments:
Related Image:
 Radiation Oncology Experts from 16 Countries Attend Technical University of Munich's International Conference on TomoTherapy 
(Date:12/1/2015)... ... ... Growth in medical payments per workers’ compensation claim in Louisiana slowed from 2011 ... according to a recent study by the Workers Compensation Research Institute (WCRI). , ... per claim with more than seven days of lost time continued to be higher ...
(Date:12/1/2015)... Wayland, MA (PRWEB) , ... December 01, 2015 , ... ... adults has a tattoo — a number even greater among Millennials (a whopping one ... there are more and more people who are dissatisfied with their ink. In fact, ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... technicians must mark the film for accurate interpretation by the radiologist. The marking ... an inventor from Sacramento, Calif., has found a way to alleviate this problem. ...
(Date:12/1/2015)... ... 01, 2015 , ... Next IT Healthcare, the leader in ... this year’s Fierce Innovation Awards: Healthcare Edition, an awards program from the publisher ... in the category of Digital Solutions for its innovative, industry-leading product, Alme Health ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... Effective Post-Affiliation Integration ,” addresses a main “pain point” for merging or aligning ... results, once a deal is signed. This quick-read guidance suggests that failing ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... , Dec. 1, 2015 Relmada Therapeutics, Inc. ... treatment of chronic pain, announced today that the company will ... be held December 1-3 at the Luxe Sunset Boulevard Hotel ... Traversa , CEO of Relmada Therapeutics, will present on Thursday, ... Time). . Please register at least 10 ...
(Date:12/1/2015)... 2015 CytRx Corporation (NASDAQ: CYTR ), ... today announced that it has reached its enrollment target ... 3 clinical trial of aldoxorubicin in patients with previously ... be completed in Q1 2016. The Phase 3 trial is ... Protocol Assessment from the FDA at 79 sites in ...
(Date:12/1/2015)... , Dec. 1, 2015  Today, ... the launch of CareFront, a first-of-its-kind population health ... diagnosed with cancer. Designed to be built into ... cancer patients with resources for their care and ... program also offers tools to help patients understand ...
Breaking Medicine Technology: